Survival in families with hereditary protein C deficiency, 1820 to 1993
OBJECTIVES —To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk ofvenous thrombotic events, and to compare it with the survival of the general population. DESIGN —Retrospective study in pedigrees of23 families with hereditary protein...
Gespeichert in:
Veröffentlicht in: | BMJ 1995-10, Vol.311 (7010), p.910-913 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 913 |
---|---|
container_issue | 7010 |
container_start_page | 910 |
container_title | BMJ |
container_volume | 311 |
creator | Allaart, C F Rosendaal, F R Noteboom, WM P Vandenbroucke, J P Briet, E |
description | OBJECTIVES —To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk ofvenous thrombotic events, and to compare it with the survival of the general population. DESIGN —Retrospective study in pedigrees of23 families with hereditary protein C deficiency for period 1820 and 1993. SETTING —23 completed family trees of 24 probandsfrom various parts of the Netherlands with symptoms of protein C deficiency. SUBJECTS —All 736 members of the 23 families with a50% or 100% probability of being (or having been) heterozygous for the genetic defect on the basis of DNA analysis or their place inthe pedigrees, following mendelian rules. MAIN OUTCOME MEASURES —Observed mortality compared with the mortality of thegeneral Dutch population; the standardised mortality ratio was calculated by dividing the observed mortality by the expected mortality. RESULTS —No excess mortality was found in the 206 proved heterozygous individuals and “obligatory transmitters” (those who havedefinitely passed on the deficiency) (standardised mortality ratio 0.95 (95% confidence interval 0.5 to 1.2)) or in the 530 familymembers with a 50% genetic probability of heterozygosity (1.10 (0.9 to 1.3)). CONCLUSION —Heterozygous individuals withhereditary protein C deficiency type I have normal survival compared with the general population. Prophylactic anticoagulant treatmentmay prevent thrombotic events in heterozygous individuals but may not be expected to improve their survival. |
doi_str_mv | 10.1136/bmj.311.7010.910 |
format | Article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2550916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>29728993</jstor_id><sourcerecordid>29728993</sourcerecordid><originalsourceid>FETCH-LOGICAL-b515t-b0c355057549ae4211cb5a2e873d3b1a7994ee9a99f5bd9ac3f4a8482da2c8c73</originalsourceid><addsrcrecordid>eNqFkc2L1DAYxoMo67Du3YtQELxox7xJ0yQXQQadVRY9rB_gJaRp6mRsmzFJZ3f_e1NmGD8ungL5PXnyvO-D0GPASwBav2yG7ZICLDnONxLwPbSAqhYlE5TeRwssmSwFUPEQXcS4xRgTyoWs2Rk640xgVvEFWl9PYe_2ui_cWHR6cL2zsbhxaVNsbLCtSzrcFbvgk82CVdHazhlnR3P3ogBBcJF8AVLSR-hBp_toL47nOfr89s2n1WV59XH9bvX6qmwYsFQ22FDGMOOsktpWBMA0TBMrOG1pA5pLWVkrtZQda1qpDe0qLSpBWk2MMJyeo1cH393UDLY1dkxB92oX3JCDKq-d-puMbqO--70i-VsJdTZ4djQI_udkY1KDi8b2vR6tn6LinNG8G5KFT_8Rbv0UxjycAp5VRAKf7fBBZYKPMdjuFAWwmltSuSWVW1JzSyq3lJ88-XOE04NjJ7_5NiYfTphITkTedOblgbuY7O2J6_BD1Zxypj58Wamv364vybp-r2a_5wf9nOS_6X4BajqyQA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777529176</pqid></control><display><type>article</type><title>Survival in families with hereditary protein C deficiency, 1820 to 1993</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Allaart, C F ; Rosendaal, F R ; Noteboom, WM P ; Vandenbroucke, J P ; Briet, E</creator><creatorcontrib>Allaart, C F ; Rosendaal, F R ; Noteboom, WM P ; Vandenbroucke, J P ; Briet, E</creatorcontrib><description>OBJECTIVES —To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk ofvenous thrombotic events, and to compare it with the survival of the general population. DESIGN —Retrospective study in pedigrees of23 families with hereditary protein C deficiency for period 1820 and 1993. SETTING —23 completed family trees of 24 probandsfrom various parts of the Netherlands with symptoms of protein C deficiency. SUBJECTS —All 736 members of the 23 families with a50% or 100% probability of being (or having been) heterozygous for the genetic defect on the basis of DNA analysis or their place inthe pedigrees, following mendelian rules. MAIN OUTCOME MEASURES —Observed mortality compared with the mortality of thegeneral Dutch population; the standardised mortality ratio was calculated by dividing the observed mortality by the expected mortality. RESULTS —No excess mortality was found in the 206 proved heterozygous individuals and “obligatory transmitters” (those who havedefinitely passed on the deficiency) (standardised mortality ratio 0.95 (95% confidence interval 0.5 to 1.2)) or in the 530 familymembers with a 50% genetic probability of heterozygosity (1.10 (0.9 to 1.3)). CONCLUSION —Heterozygous individuals withhereditary protein C deficiency type I have normal survival compared with the general population. Prophylactic anticoagulant treatmentmay prevent thrombotic events in heterozygous individuals but may not be expected to improve their survival.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.311.7010.910</identifier><identifier>PMID: 7580547</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Adolescent ; Adult ; Age Factors ; Age groups ; Aged ; Aged, 80 and over ; Anticoagulants ; Child ; Child, Preschool ; Children ; Death ; DNA ; Family members ; Female ; Heterozygote ; Humans ; Infant ; Male ; Medical genetics ; Middle Aged ; Mortality ; Netherlands ; Pedigree ; Protein C - genetics ; Protein C Deficiency ; Ratios ; Retrospective Studies ; Survival Rate</subject><ispartof>BMJ, 1995-10, Vol.311 (7010), p.910-913</ispartof><rights>1995 BMJ Publishing Group Ltd.</rights><rights>Copyright 1995 British Medical Journal</rights><rights>Copyright: 1995 (c) 1995 BMJ Publishing Group Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b515t-b0c355057549ae4211cb5a2e873d3b1a7994ee9a99f5bd9ac3f4a8482da2c8c73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/29728993$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/29728993$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,27902,27903,57994,58227</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7580547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Allaart, C F</creatorcontrib><creatorcontrib>Rosendaal, F R</creatorcontrib><creatorcontrib>Noteboom, WM P</creatorcontrib><creatorcontrib>Vandenbroucke, J P</creatorcontrib><creatorcontrib>Briet, E</creatorcontrib><title>Survival in families with hereditary protein C deficiency, 1820 to 1993</title><title>BMJ</title><addtitle>BMJ</addtitle><description>OBJECTIVES —To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk ofvenous thrombotic events, and to compare it with the survival of the general population. DESIGN —Retrospective study in pedigrees of23 families with hereditary protein C deficiency for period 1820 and 1993. SETTING —23 completed family trees of 24 probandsfrom various parts of the Netherlands with symptoms of protein C deficiency. SUBJECTS —All 736 members of the 23 families with a50% or 100% probability of being (or having been) heterozygous for the genetic defect on the basis of DNA analysis or their place inthe pedigrees, following mendelian rules. MAIN OUTCOME MEASURES —Observed mortality compared with the mortality of thegeneral Dutch population; the standardised mortality ratio was calculated by dividing the observed mortality by the expected mortality. RESULTS —No excess mortality was found in the 206 proved heterozygous individuals and “obligatory transmitters” (those who havedefinitely passed on the deficiency) (standardised mortality ratio 0.95 (95% confidence interval 0.5 to 1.2)) or in the 530 familymembers with a 50% genetic probability of heterozygosity (1.10 (0.9 to 1.3)). CONCLUSION —Heterozygous individuals withhereditary protein C deficiency type I have normal survival compared with the general population. Prophylactic anticoagulant treatmentmay prevent thrombotic events in heterozygous individuals but may not be expected to improve their survival.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Age groups</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Death</subject><subject>DNA</subject><subject>Family members</subject><subject>Female</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical genetics</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Netherlands</subject><subject>Pedigree</subject><subject>Protein C - genetics</subject><subject>Protein C Deficiency</subject><subject>Ratios</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><issn>0959-8138</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc2L1DAYxoMo67Du3YtQELxox7xJ0yQXQQadVRY9rB_gJaRp6mRsmzFJZ3f_e1NmGD8ungL5PXnyvO-D0GPASwBav2yG7ZICLDnONxLwPbSAqhYlE5TeRwssmSwFUPEQXcS4xRgTyoWs2Rk640xgVvEFWl9PYe_2ui_cWHR6cL2zsbhxaVNsbLCtSzrcFbvgk82CVdHazhlnR3P3ogBBcJF8AVLSR-hBp_toL47nOfr89s2n1WV59XH9bvX6qmwYsFQ22FDGMOOsktpWBMA0TBMrOG1pA5pLWVkrtZQda1qpDe0qLSpBWk2MMJyeo1cH393UDLY1dkxB92oX3JCDKq-d-puMbqO--70i-VsJdTZ4djQI_udkY1KDi8b2vR6tn6LinNG8G5KFT_8Rbv0UxjycAp5VRAKf7fBBZYKPMdjuFAWwmltSuSWVW1JzSyq3lJ88-XOE04NjJ7_5NiYfTphITkTedOblgbuY7O2J6_BD1Zxypj58Wamv364vybp-r2a_5wf9nOS_6X4BajqyQA</recordid><startdate>19951007</startdate><enddate>19951007</enddate><creator>Allaart, C F</creator><creator>Rosendaal, F R</creator><creator>Noteboom, WM P</creator><creator>Vandenbroucke, J P</creator><creator>Briet, E</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19951007</creationdate><title>Survival in families with hereditary protein C deficiency, 1820 to 1993</title><author>Allaart, C F ; Rosendaal, F R ; Noteboom, WM P ; Vandenbroucke, J P ; Briet, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b515t-b0c355057549ae4211cb5a2e873d3b1a7994ee9a99f5bd9ac3f4a8482da2c8c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Age groups</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Death</topic><topic>DNA</topic><topic>Family members</topic><topic>Female</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical genetics</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Netherlands</topic><topic>Pedigree</topic><topic>Protein C - genetics</topic><topic>Protein C Deficiency</topic><topic>Ratios</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Allaart, C F</creatorcontrib><creatorcontrib>Rosendaal, F R</creatorcontrib><creatorcontrib>Noteboom, WM P</creatorcontrib><creatorcontrib>Vandenbroucke, J P</creatorcontrib><creatorcontrib>Briet, E</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Allaart, C F</au><au>Rosendaal, F R</au><au>Noteboom, WM P</au><au>Vandenbroucke, J P</au><au>Briet, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival in families with hereditary protein C deficiency, 1820 to 1993</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>1995-10-07</date><risdate>1995</risdate><volume>311</volume><issue>7010</issue><spage>910</spage><epage>913</epage><pages>910-913</pages><issn>0959-8138</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><abstract>OBJECTIVES —To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk ofvenous thrombotic events, and to compare it with the survival of the general population. DESIGN —Retrospective study in pedigrees of23 families with hereditary protein C deficiency for period 1820 and 1993. SETTING —23 completed family trees of 24 probandsfrom various parts of the Netherlands with symptoms of protein C deficiency. SUBJECTS —All 736 members of the 23 families with a50% or 100% probability of being (or having been) heterozygous for the genetic defect on the basis of DNA analysis or their place inthe pedigrees, following mendelian rules. MAIN OUTCOME MEASURES —Observed mortality compared with the mortality of thegeneral Dutch population; the standardised mortality ratio was calculated by dividing the observed mortality by the expected mortality. RESULTS —No excess mortality was found in the 206 proved heterozygous individuals and “obligatory transmitters” (those who havedefinitely passed on the deficiency) (standardised mortality ratio 0.95 (95% confidence interval 0.5 to 1.2)) or in the 530 familymembers with a 50% genetic probability of heterozygosity (1.10 (0.9 to 1.3)). CONCLUSION —Heterozygous individuals withhereditary protein C deficiency type I have normal survival compared with the general population. Prophylactic anticoagulant treatmentmay prevent thrombotic events in heterozygous individuals but may not be expected to improve their survival.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>7580547</pmid><doi>10.1136/bmj.311.7010.910</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ, 1995-10, Vol.311 (7010), p.910-913 |
issn | 0959-8138 1468-5833 1756-1833 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2550916 |
source | Jstor Complete Legacy; MEDLINE; Alma/SFX Local Collection |
subjects | Adolescent Adult Age Factors Age groups Aged Aged, 80 and over Anticoagulants Child Child, Preschool Children Death DNA Family members Female Heterozygote Humans Infant Male Medical genetics Middle Aged Mortality Netherlands Pedigree Protein C - genetics Protein C Deficiency Ratios Retrospective Studies Survival Rate |
title | Survival in families with hereditary protein C deficiency, 1820 to 1993 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T08%3A45%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20in%20families%20with%20hereditary%20protein%20C%20deficiency,%201820%20to%201993&rft.jtitle=BMJ&rft.au=Allaart,%20C%20F&rft.date=1995-10-07&rft.volume=311&rft.issue=7010&rft.spage=910&rft.epage=913&rft.pages=910-913&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.311.7010.910&rft_dat=%3Cjstor_pubme%3E29728993%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777529176&rft_id=info:pmid/7580547&rft_jstor_id=29728993&rfr_iscdi=true |